<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03766113</url>
  </required_header>
  <id_info>
    <org_study_id>35RC18_9813_NeuroFB-AVC</org_study_id>
    <nct_id>NCT03766113</nct_id>
  </id_info>
  <brief_title>Neurofeedback for Upper-limb Recovery After Stroke</brief_title>
  <acronym>NeuroFB-AVC</acronym>
  <official_title>Effect of Unimodal (EEG) and Bimodal (EEG-fMRI) Neurofeedback on Upper Limb Recovery After Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Interventional study with minimal risks and constraints, prospective, monocentric.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neurofeedback (NF) consists on training self-regulation of brain activity by providing&#xD;
      real-time information about the participant brain function NF approaches in stroke are&#xD;
      usually based on real-time monitoring of brain activity using EEG-NF and involve chronic&#xD;
      stroke. Recent studies have revealed the potential of combining EEG and fMRI to achieve a&#xD;
      more efficient and specific self-regulation, which may be critical in clinical applications.&#xD;
&#xD;
      The aim of this study is to optimize the neurofeedback method coupling EEG and fMRI in&#xD;
      healthy subjects then to evaluate the effect of an EEG-NF and a neurofeedback coupling EEG&#xD;
      and fMRI versus motor imagery on recovery in the early and chronic stage after stroke.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 20, 2018</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CXa: Active range of motion at elbow and wirst (from Tardieu scale)</measure>
    <time_frame>Change in Cxa between baseline and the end of the study</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">116</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Healthy volunteer</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>50 subjects&#xD;
A single neurofeedback coupling electroencephalogram and functional MRI in time actual .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients at the early stage after stroke</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>30 subjects&#xD;
Effectiveness of an electroencephalogram-neurofeedback</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients at the chronic stage after stroke</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>36 subjects&#xD;
Effectiveness of a neurofeedback coupling electroencephalogram and functional MRI in time actual</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neurofeedback coupling electroencephalogram and functional MRI in time actual</intervention_name>
    <description>One visit : Neurofeedback coupling electroencephalogram and functional MRI in time actual</description>
    <arm_group_label>Healthy volunteer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Electroencephalogram-neurofeedback program or Neurofeedback-free mental imaging program with electroencephalogram recording</intervention_name>
    <description>Interventional group (Electroencephalogram-neurofeedback program) : 24 minutes, 3 times a week for 12 weeks in addition to the traditional rehabilitation program.&#xD;
Controle Group (Neurofeedback-free mental imaging) : 24 minutes, 3 times a week for 12 weeks in addition to the traditional rehabilitation program of reference.</description>
    <arm_group_label>Patients at the early stage after stroke</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neurofeedback coupling electroencephalogram and functional MRI in time actual or a neurofeedback-free mental imaging program with electroencephalogram recording</intervention_name>
    <description>Interventional group (5 weeks) : 5 sessions of neurofeedback coupling electroencephalogram and functional MRI in time actual and 9 sessions of electroencephalogram-neurofeedback program&#xD;
Controle Group (5 weeks) : 14 sessions of neurofeedback-free mental imaging program</description>
    <arm_group_label>Patients at the chronic stage after stroke</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients at the early stage after stroke : Ischemic or hemorrhagic unilateral stroke ;&#xD;
             adult (age greater than or equal to 18 years) under 80, of both sexes ; stroke less&#xD;
             than 1 month old ; upper limb deficit defined by a SAFE score &lt;8 (SAFE Stinear&#xD;
             protocol) at D3 of stroke; absence of comprehension difficulties limiting&#xD;
             participation ; with or without homonymous lateral hemianopia ; with or without&#xD;
             visuospatial henegligence ; free, informed and written consent signed by the patient&#xD;
             or a member of his entourage (in the case of a patient able to understand the&#xD;
             information and to express his / her consent but presenting motor difficulties leading&#xD;
             to an invalid signature).&#xD;
&#xD;
          -  Patients at the chronic stage after stroke : Ischemic or unilateral supra-tentorial&#xD;
             unilateral cerebral hemorrhage ; adult (age greater than or equal to 18 years) under&#xD;
             80, of both sexes ; stroke more than 6 months ; motor abilities of the upper limb&#xD;
             defines as &quot;poor&quot; to &quot;noticeable&quot; according to Hoonhorst on the Fugl-Meyer upper limb&#xD;
             scale, ranging between 22 and 53 out of 66 ; absence of comprehension difficulties&#xD;
             limiting participation ; with or without homonymous lateral hemianopia ; with or&#xD;
             without visuospatial henegligence ; free, informed and written consent signed by the&#xD;
             patient or a member of his entourage (in the case of a patient able to understand the&#xD;
             information and to express his / her consent but presenting motor difficulties leading&#xD;
             to an invalid signature).&#xD;
&#xD;
          -  Healthy Volunteers : Adult (age greater than or equal to 18 years) under 80, of both&#xD;
             sexes ; Free, informed and written consent signed by the volunteer.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients at the early stage after stroke : Ischemic or haemorrhagic involvement of the&#xD;
             brainstem ; multiple stroke ; aphasia with major comprehension disorder ; major&#xD;
             persons subject to legal protection, persons deprived of their liberty.&#xD;
&#xD;
          -  Patients at the chronic stage after stroke : Ischemic or haemorrhagic involvement of&#xD;
             the brainstem ; multiple stroke ; aphasia with major comprehension disorder ; vascular&#xD;
             leukopathy important to MRI (Fazekas 3) in order not to interfere with the&#xD;
             interpretation of MRI ; contraindication to MRI ; major persons subject to legal&#xD;
             protection, persons deprived of their liberty.&#xD;
&#xD;
          -  Healthy Volunteers : Contraindication to MRI ; pregnancy ; breastfeeding ; major&#xD;
             persons subject to legal protection, persons deprived of their liberty&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Simon Butet</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rennes University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Simon Butet</last_name>
    <phone>2 99 28 42 18</phone>
    <phone_ext>+33</phone_ext>
    <email>simon.butet@chu-rennes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Isabelle Bonan</last_name>
    <phone>2 99 28 42 18</phone>
    <phone_ext>+33</phone_ext>
    <email>isabelle.bonan@chu-rennes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rennes University Hospital</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon Butet</last_name>
      <phone>2 99 28 42 18</phone>
      <phone_ext>+33</phone_ext>
      <email>simon.butet@chu-rennes.fr</email>
    </contact>
    <contact_backup>
      <last_name>Isabelle Bonan</last_name>
      <phone>2 99 28 42 18</phone>
      <phone_ext>+33</phone_ext>
      <email>isabelle.bonan@chu-rennes.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 22, 2018</study_first_submitted>
  <study_first_submitted_qc>December 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2018</study_first_posted>
  <last_update_submitted>December 15, 2020</last_update_submitted>
  <last_update_submitted_qc>December 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neurofeedback ; fMRI ; EEG ; BCI ; Motor imagery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

